Offer - Urjas Oil for just ₹ 1 X
Metosartan CH Tablet (10) is an allopathic medicine The correct dosage of Metosartan CH Tablet (10) depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Metosartan CH Tablet (10) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Metosartan CH Tablet (10) safe for pregnant women?
Metosartan CH Tablet (10) should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Metosartan CH Tablet (10) safe during breastfeeding?
Side effects of Metosartan CH Tablet (10) for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Metosartan CH Tablet (10) on the Kidneys?
Metosartan CH Tablet (10) is completely safe for kidneys.
What is the effect of Metosartan CH Tablet (10) on the Liver?
Metosartan CH Tablet (10) is rarely harmful for the liver.
What is the effect of Metosartan CH Tablet (10) on the Heart?
Metosartan CH Tablet (10) is rarely harmful for the heart.
Metosartan CH Tablet (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Metosartan CH Tablet (10) unless your doctor advises you to do so -
Is this Metosartan CH Tablet (10) habit forming or addictive?
Metosartan CH Tablet (10) does not cause addiction.
Interaction between Food and Metosartan CH Tablet (10)
Taking Metosartan CH Tablet (10) with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Metosartan CH Tablet (10)
Consuming Metosartan CH Tablet (10) with alcohol can have many serious effects on your body.
Yes, Metosartan CH Tablet (10) is safe to use, if taken in prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as diarrhea, headache, and dizziness. If you experience any discomfort after taking this do inform your doctor.
Metosartan CH Tablet (10) is a brand name of chlorthalidone and it is available in the form of tablets. It belongs to the class of drugs known as thiazide diuretics. Metosartan CH Tablet (10) is a prescription drug that is used in hypertension (high blood pressure) and reduces swelling of liver and kidney due to excess accumulation of fluid.
Yes, Metosartan CH Tablet (10) may cause weight loss. If you are experiencing the same after taking this drug, you are advised to consult it with your doctor.
Yes, Metosartan CH Tablet (10) may cause itching or rashes but it occurs rarely. If you experience excessive rashes or itching then consult it with your doctor without any further delay.
No, Metosartan CH Tablet (10) is a prescription drug so do not take it without consulting a doctor. It can be harmful to the patient to take this medicine without a doctor's recommendation because it can cause very unpleasant side effects. Hence, the patient should seek doctors advice before taking this medication by himself or herself.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)